Endo Manufacturing Co., Ltd. Logo

Endo Manufacturing Co., Ltd.

7841.T

(2.0)
Stock Price

1.282,00 JPY

-0.08% ROA

-0.11% ROE

-417.16x PER

Market Cap.

8.350.856.172,00 JPY

1.54% DER

2.1% Yield

-0.13% NPM

Endo Manufacturing Co., Ltd. Stock Analysis

Endo Manufacturing Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Endo Manufacturing Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.35x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a low debt to equity ratio (2%), which means it has a small amount of debt compared to the ownership it holds

3 ROE

The stock's ROE falls within an average range (1.62%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (1.28%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 Assets Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

6 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

7 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-163.121) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Endo Manufacturing Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Endo Manufacturing Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Endo Manufacturing Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Endo Manufacturing Co., Ltd. Revenue
Year Revenue Growth
2007 20.188.807.000
2008 18.695.916.000 -7.99%
2009 13.361.561.000 -39.92%
2010 17.070.971.000 21.73%
2011 15.365.312.000 -11.1%
2012 17.486.367.000 12.13%
2013 15.902.388.000 -9.96%
2014 13.815.766.000 -15.1%
2015 12.587.518.000 -9.76%
2016 11.426.554.000 -10.16%
2018 11.786.596.000 3.05%
2019 9.773.969.000 -20.59%
2020 8.276.401.000 -18.09%
2021 12.589.516.000 34.26%
2022 14.582.181.000 13.67%
2023 14.734.024.000 1.03%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Endo Manufacturing Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Endo Manufacturing Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Endo Manufacturing Co., Ltd. EBITDA
Year EBITDA Growth
2007 3.349.150.000
2008 2.600.749.000 -28.78%
2009 1.724.757.000 -50.79%
2010 2.365.694.000 27.09%
2011 1.994.509.000 -18.61%
2012 2.028.727.000 1.69%
2013 1.232.483.000 -64.6%
2014 1.359.894.000 9.37%
2015 1.897.652.000 28.34%
2016 2.135.063.000 11.12%
2018 1.848.335.000 -15.51%
2019 1.157.486.000 -59.69%
2020 1.003.953.000 -15.29%
2021 2.850.476.000 64.78%
2022 3.052.765.000 6.63%
2023 560.536.000 -444.62%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Endo Manufacturing Co., Ltd. Gross Profit
Year Gross Profit Growth
2007 3.873.891.000
2008 3.901.809.000 0.72%
2009 1.940.467.000 -101.08%
2010 3.273.971.000 40.73%
2011 2.973.553.000 -10.1%
2012 2.750.276.000 -8.12%
2013 1.800.703.000 -52.73%
2014 2.118.579.000 15%
2015 2.468.879.000 14.19%
2016 2.757.876.000 10.48%
2018 2.463.341.000 -11.96%
2019 1.503.972.000 -63.79%
2020 1.450.021.000 -3.72%
2021 3.564.360.000 59.32%
2022 3.726.614.000 4.35%
2023 2.100.504.000 -77.42%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Endo Manufacturing Co., Ltd. Net Profit
Year Net Profit Growth
2007 1.373.515.000
2008 611.266.000 -124.7%
2009 -208.825.000 392.72%
2010 868.459.000 124.05%
2011 809.394.000 -7.3%
2012 484.426.000 -67.08%
2013 -569.762.000 185.02%
2014 -301.928.000 -88.71%
2015 -4.943.000 -6008.19%
2016 1.051.493.000 100.47%
2018 563.821.000 -86.49%
2019 265.682.000 -112.22%
2020 -88.102.000 401.56%
2021 1.601.592.000 105.5%
2022 796.805.000 -101%
2023 -36.220.000 2299.9%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Endo Manufacturing Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 149
2008 67 -124.24%
2009 -23 386.96%
2010 96 124.21%
2011 88 -7.95%
2012 55 -60%
2013 -65 184.62%
2014 -35 -91.18%
2015 -1 0%
2016 120 100%
2018 65 -87.5%
2019 30 -113.33%
2020 -10 400%
2021 183 105.46%
2022 91 -101.1%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Endo Manufacturing Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2007 431.978.000
2008 -749.720.000 157.62%
2009 463.548.000 261.74%
2010 1.972.489.000 76.5%
2011 662.824.000 -197.59%
2012 -11.706.000 5762.26%
2013 1.882.311.000 100.62%
2014 371.158.000 -407.15%
2015 1.245.388.000 70.2%
2016 1.821.811.000 31.64%
2018 -182.205.000 1099.87%
2019 681.630.000 126.73%
2020 -73.951.000 1021.73%
2021 709.061.000 110.43%
2022 889.842.000 20.32%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Endo Manufacturing Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2007 2.100.462.000
2008 1.468.881.000 -43%
2009 1.577.183.000 6.87%
2010 2.980.166.000 47.08%
2011 1.017.440.000 -192.91%
2012 1.271.002.000 19.95%
2013 2.650.940.000 52.05%
2014 1.011.052.000 -162.2%
2015 1.667.524.000 39.37%
2016 1.948.359.000 14.41%
2018 1.310.371.000 -48.69%
2019 1.618.565.000 19.04%
2020 599.617.000 -169.93%
2021 1.577.907.000 62%
2022 1.925.236.000 18.04%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Endo Manufacturing Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2007 1.668.484.000
2008 2.218.601.000 24.8%
2009 1.113.635.000 -99.22%
2010 1.007.677.000 -10.52%
2011 354.616.000 -184.16%
2012 1.282.708.000 72.35%
2013 768.629.000 -66.88%
2014 639.894.000 -20.12%
2015 422.136.000 -51.58%
2016 126.548.000 -233.58%
2018 1.492.576.000 91.52%
2019 936.935.000 -59.3%
2020 673.568.000 -39.1%
2021 868.846.000 22.48%
2022 1.035.394.000 16.09%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Endo Manufacturing Co., Ltd. Equity
Year Equity Growth
2007 11.525.939.000
2008 11.016.792.000 -4.62%
2009 10.921.147.000 -0.88%
2010 11.540.642.000 5.37%
2011 11.581.384.000 0.35%
2012 12.966.451.000 10.68%
2013 13.350.794.000 2.88%
2014 14.391.494.000 7.23%
2015 13.269.242.000 -8.46%
2016 13.962.482.000 4.97%
2018 15.117.867.000 7.64%
2019 16.022.741.000 5.65%
2020 15.239.644.000 -5.14%
2021 16.734.410.000 8.93%
2022 18.372.604.000 8.92%
2023 19.506.524.000 5.81%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Endo Manufacturing Co., Ltd. Assets
Year Assets Growth
2007 20.314.873.000
2008 19.121.002.000 -6.24%
2009 17.783.018.000 -7.52%
2010 18.695.149.000 4.88%
2011 17.688.053.000 -5.69%
2012 18.626.047.000 5.04%
2013 18.343.511.000 -1.54%
2014 19.673.984.000 6.76%
2015 17.561.958.000 -12.03%
2016 17.718.423.000 0.88%
2018 18.604.627.000 4.76%
2019 18.804.741.000 1.06%
2020 17.964.046.000 -4.68%
2021 20.479.223.000 12.28%
2022 21.868.342.000 6.35%
2023 24.357.845.000 10.22%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Endo Manufacturing Co., Ltd. Liabilities
Year Liabilities Growth
2007 8.788.934.000
2008 8.104.210.000 -8.45%
2009 6.861.871.000 -18.1%
2010 7.154.507.000 4.09%
2011 6.106.669.000 -17.16%
2012 5.659.596.000 -7.9%
2013 4.992.717.000 -13.36%
2014 5.282.490.000 5.49%
2015 4.292.716.000 -23.06%
2016 3.755.941.000 -14.29%
2018 3.486.760.000 -7.72%
2019 2.782.000.000 -25.33%
2020 2.724.402.000 -2.11%
2021 3.744.813.000 27.25%
2022 3.495.738.000 -7.13%
2023 4.851.321.000 27.94%

Endo Manufacturing Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1745.01
Net Income per Share
-2.29
Price to Earning Ratio
-417.16x
Price To Sales Ratio
0.55x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
0.43
EV to Sales
-0.03
EV Over EBITDA
-0.42
EV to Operating CashFlow
0
EV to FreeCashFlow
0
Earnings Yield
-0
FreeCashFlow Yield
0
Market Cap
8,35 Bil.
Enterprise Value
-0,44 Bil.
Graham Number
338.67
Graham NetNet
938.47

Income Statement Metrics

Net Income per Share
-2.29
Income Quality
0
ROE
-0
Return On Assets
-0
Return On Capital Employed
0.04
Net Income per EBT
-0.02
EBT Per Ebit
1.06
Ebit per Revenue
0.06
Effective Tax Rate
1.02

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.17
Operating Profit Margin
0.06
Pretax Profit Margin
0.07
Net Profit Margin
-0

Dividends

Dividend Yield
0.02
Dividend Yield %
2.1
Payout Ratio
0
Dividend Per Share
20

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-0
Return on Tangible Assets
-0
Days Sales Outstanding
82.32
Days Payables Outstanding
60.61
Days of Inventory on Hand
74.45
Receivables Turnover
4.43
Payables Turnover
6.02
Inventory Turnover
4.9
Capex per Share
0

Balance Sheet

Cash per Share
1.050,53
Book Value per Share
2.229,11
Tangible Book Value per Share
2229.11
Shareholders Equity per Share
2229.11
Interest Debt per Share
34.52
Debt to Equity
0.02
Debt to Assets
0.01
Net Debt to EBITDA
-8.38
Current Ratio
4.69
Tangible Asset Value
19,39 Bil.
Net Current Asset Value
10,99 Bil.
Invested Capital
0.02
Working Capital
12,46 Bil.
Intangibles to Total Assets
0
Average Receivables
3,42 Bil.
Average Payables
1,98 Bil.
Average Inventory
2637276500
Debt to Market Cap
0.04

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Endo Manufacturing Co., Ltd. Dividends
Year Dividends Growth
2003 12
2004 10 -20%
2007 10 0%
2011 10 0%
2012 10 0%
2013 10 0%
2014 10 0%
2015 8 -25%
2016 8 0%
2017 24 66.67%
2018 24 0%
2019 3 -700%
2020 12 75%
2021 15 20%
2022 18 16.67%
2023 0 0%

Endo Manufacturing Co., Ltd. Profile

About Endo Manufacturing Co., Ltd.

Endo Manufacturing Co., Ltd., together with its subsidiaries, manufactures and sells golf club heads, metal sleeve products, forged components, and medical devices in Japan and internationally. The company offers golf club heads under the Epon Golf brand; and medical devices, including hip joint, femoral head, femoral cup, trauma plate, tibial tray, and knee and femur components. It also provides metal sleeves, such as metal tubes, high precision ultra-thin pipes, heat pipes, bellows base materials, and IH parts for medical parts, automobile parts, and the new energy-related sector; and forged parts, such as engine and transmission gears for automobiles and motorcycles, as well as agricultural machinery parts and others. The company was incorporated in 1950 and is headquartered in Tsubame, Japan.

CEO
Mr. Taishi Watabe
Employee
1.282
Address
987, Higashiota
Tsubame, 959-1289

Endo Manufacturing Co., Ltd. Executives & BODs

Endo Manufacturing Co., Ltd. Executives & BODs
# Name Age
1 Mr. Taishi Watabe
President & Representative Director
70

Endo Manufacturing Co., Ltd. Competitors